To understand the effect of ruxolitinib on STAT3 phosphorylation, we incubated OVCAR-8, MDAH2774, and SKOV3 human ovarian cancer cells with increasing concentrations of ruxolitinib followed by Western blot analysis. Here, STAT3 is linked to ovarian cancer.